Transdermal botulinum toxin compositions

Details for Australian Patent Application No. 2003267987 (hide)

International Classifications

Event Publications

8 January 2004 Complete Application Filed

Priority application(s): 10/194,805 11.07.02 US

18 March 2004 Application Open to Public Inspection

Published as AU-B-2003267987

17 August 2006 Application Accepted

Published as AU-B-2003267987

7 December 2006 Opposition Lodged

Solstice Neurosciences, Inc. has lodged an opposition against Allergan, Inc.

31 May 2007 Opposition Withdrawn

The opposition by Solstice Neurosciences, Inc. against Allergan, Inc has been withdrawn.

5 July 2007 Standard Patent Sealed

29 November 2007 Section 223 Application Allowed

Allergan, Inc. The time in which to file search results has been extended to 22 Aug 2007. Address for service in Australia - Davies Collison Cave 255 Elizabeth Street Sydney NSW 2000

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.